New FDA Hepatitis List Serve
March 12, 2009
The Food and Drug Administration is launching a new hepatitis list serve. This new e-mail list will provide updates on safety and regulatory issues related to hepatitis B and C products as they become available (rather than on a regularly scheduled basis).
The e-mail list is intended to give patients, industry, academia, government agencies, and other interested parties, one source for FDA hepatitis B and C related information on a variety of topics, including:
You can subscribe to the new hepatitis e-mail list by simply clicking the link below:
or pasting it into your browser.
You will get an e-mail acknowledgment shortly after signing up.
This article was provided by U.S. Food and Drug Administration. Visit the FDA's website to find out more about their activities and publications.